Kim, Mijin http://orcid.org/0000-0002-7781-9466
Panagiotakopoulou, Magdalini http://orcid.org/0000-0001-6293-4579
Chen, Chen http://orcid.org/0000-0002-4803-0183
Ruiz, Stephen B. http://orcid.org/0000-0002-1634-9798
Ganesh, Karuna http://orcid.org/0000-0002-4948-1082
Tammela, Tuomas http://orcid.org/0000-0003-3675-6961
Heller, Daniel A. http://orcid.org/0000-0002-6866-0000
Article History
Accepted: 25 May 2023
First Online: 23 June 2023
Competing interests
: D.A.H. is a co-founder and officer with equity interest in Lime Therapeutics, Inc. and co-founder with equity interest in Selectin Therapeutics Inc. and Resident Diagnostics, Inc. and a member of the scientific advisory board of Concarlo Therapeutics, Inc., Nanorobotics Inc. and Mediphage Bioceuticals, Inc. T.T. has research support from ONO Pharma USA, Inc. (unrelated to this work) and is a member of the scientific advisory board of Lime Therapeutics, Inc. with equity interest. M.K., M.P., C.C., S.B.R. and K.G. declare no competing interests.